Fas polymorphisms influence susceptibility to autoimmune hepatitis. (Q54661241)

2 June 2018

title

Fas polymorphisms influence susceptibility to autoimmune hepatitis. (English)

1 reference

2 June 2018

author name string

Akira Hiraide

1

1 reference

2 June 2018

Fumio Imazeki

2

1 reference

2 June 2018

Osamu Yokosuka

3

1 reference

2 June 2018

Tatsuo Kanda

4

1 reference

2 June 2018

Hiroshige Kojima

5

1 reference

2 June 2018

Kenichi Fukai

6

1 reference

2 June 2018

Yoichi Suzuki

7

1 reference

2 June 2018

Akira Hata

8

1 reference

2 June 2018

Hiromitsu Saisho

9

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 June 2005

1 reference

2 June 2018

The American Journal of Gastroenterology

published in

1 reference

2 June 2018

volume

100

1 reference

2 June 2018

issue

6

1 reference

2 June 2018

page(s)

1322-1329

1 reference

2 June 2018

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Apoptosis and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Interferon-activated signal transduction to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41053.X

10.1111/J.1572-0241.2005.41053.X

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018